Profil
Christopher Rovaldi worked as Principal at Cubist Pharmaceuticals LLC from 2000 to 2004.
Then worked as Principal at Idenix Pharmaceuticals LLC from 2004 to 2007.
Worked at Acceleron Pharma, Inc. from 2007 to 2018, including the role of Senior VP-Program Management & Operations from 2013 to 2018.
Worked at Periodontix, Inc. as Senior Research Associate.
Worked at Keros Therapeutics, Inc. from 2022 to 2025, including the role of President & Chief Operating Officer from 2024 to 2025.
Mr. Rovaldi completed undergraduate and graduate degrees at the University of New Hampshire.
Tidigare kända positioner av Christopher Rovaldi
| Företag | Position | Slut |
|---|---|---|
| KEROS THERAPEUTICS, INC. | President | 2025-08-18 |
| ACCELERON PHARMA INC. | Verksamhetschef | 2018-05-01 |
| IDENIX PHARMACEUTICALS INC | Företagsledare/Principal | 2007-01-01 |
| CUBIST PHARMACEUTICALS INC | Företagsledare/Principal | 2004-01-01 |
Periodontix, Inc.
Periodontix, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development in the biopharmaceutical industry; develops next generation antimicrobial agents for the prevention and treatment of each stage of periodontal disease | Företagsledare/Principal | - |
Christopher Rovaldis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Periodontix, Inc.
Periodontix, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development in the biopharmaceutical industry; develops next generation antimicrobial agents for the prevention and treatment of each stage of periodontal disease | Commercial Services |
University of New Hampshire
University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keros Therapeutics, Inc.
Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
















